| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.082 | 0.009 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |